electroCore to Participate at the 38th Annual Roth Conference

electroCore (Nasdaq: ECOR) management will participate in the 38th Annual Roth Conference March 22–24, 2026, at the Ritz-Carlton in Laguna Niguel, California.

Rhea-AI Summary

electroCore (Nasdaq: ECOR) management will participate in the 38th Annual Roth Conference March 22–24, 2026, at the Ritz-Carlton in Laguna Niguel, California. CFO Joshua Lev will host one-on-one investor meetings. Investors can schedule via their Roth representative or by emailing investors@electrocore.com.

Argus Mar 10 session

-2.11% close to close Open Argus

Details

News Market Reaction – ECOR

In the Mar 10 session, ECOR declined 2.11%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights ECOR management’s participation in the 38th Annual Roth Conference from...

Analysis

This announcement highlights ECOR management’s participation in the 38th Annual Roth Conference from March 22–24, offering one-on-one meeting access but no new financial or clinical data. In recent months, the company reported strong revenue growth and notable clinical and performance-study updates with mixed market reactions. Investors monitoring this event typically focus on any subsequent presentations, updated guidance, or follow-on SEC filings that might emerge from the increased investor engagement.

Key Figures

Conference edition: 38th Annual Conference dates: March 22–24

Conference edition

38th Annual

Roth Conference mentioned in the press release

Conference dates

March 22–24

Timing of the Roth Conference participation

Historical Context

5 past events · Latest: Jan 21

5 events

1. Jan 21

   PTSD study collaboration

   24h Move

   +10.2%

   Announcement of PTSD study using gammaCore Sapphire with up to 40 adults.

2. Jan 20

   Prelim 2025 update

   24h Move

   -3.6%

   Preliminary 2025 results guiding to ~26% revenue growth and record sales.

3. Dec 02

   TAC-STIM performance data

   24h Move

   -0.4%

   Peer‑reviewed data showing significant performance and mood improvements with tVNS.

4. Nov 10

   Conference participation

   24h Move

   +1.3%

   Announcement of participation at a Canaccord MedTech and digital health forum.

5. Nov 05

   Q3 2025 earnings

   24h Move

   +23.2%

   Record Q3 net sales, strong growth, and raised full‑year 2025 revenue guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

bioelectronic medicine

1 terms

bioelectronic medicine medical

"electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced"

Bioelectronic medicine uses small implanted or wearable devices to change the body’s electrical or nerve signals to prevent or treat illness instead of relying only on drugs. Think of it like a pacemaker for different organs: it can turn problematic signals up or down to relieve symptoms. For investors it matters because successful devices can open new treatment markets, offer recurring revenue from device sales and follow‑up care, and carry clear clinical and regulatory risks that affect value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today that management will participate in the 38th Annual Roth Conference March 22-24 at the Ritz-Carlton in Laguna Niguel, California. Joshua Lev, Chief Financial Officer, will host one-on-one meetings at the conference.

Investors attending this event who are interested in scheduling a meeting with management can do so by contacting their respective Roth representative, or by emailing investors@electrocore.com for more information.

About the Roth Capital Partners Conference
The Annual ROTH Conference is one of the largest in the nation for small-cap companies, combining company presentations, Q&A sessions and management 1-on-1 meetings. The format provides investors with the opportunity to hear from and meet with executive management from approximately 500 private and public companies in a variety of growth sectors. Roth’s award-winning Research Team identifies distinguished presenting companies across broad sectors, including consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, technology and more.

About electroCore, Inc.
electroCore, Inc. and its subsidiaries (“electroCore” or the “Company”) is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation, or nVNS, and the Quell^® Fibromyalgia. Additionally, the Company commercializes its handheld and personal use Trvuaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact

ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will electroCore (ECOR) management attend the 38th Annual Roth Conference?

Management will attend March 22–24, 2026 at the Ritz-Carlton in Laguna Niguel. According to electroCore, company executives will meet investors one-on-one and participate in conference activities across those dates.

Who from electroCore (ECOR) will be available for investor meetings at the Roth Conference?

Joshua Lev, electroCore's Chief Financial Officer, will host one-on-one meetings at the conference. According to electroCore, investors can request meetings via Roth representatives or by emailing investors@electrocore.com.

How can investors schedule a meeting with electroCore (ECOR) at the Roth Conference?

Investors should contact their Roth representative or email investors@electrocore.com to request a meeting. According to electroCore, meetings will be arranged through Roth or the company’s investor email for interested attendees.

Where is the 38th Annual Roth Conference, where electroCore (ECOR) will participate, held?

The conference runs at the Ritz-Carlton in Laguna Niguel, California, March 22–24, 2026. According to electroCore, management will be onsite for investor meetings and conference sessions during those dates.

Will electroCore (ECOR) provide a public presentation or only one-on-one meetings at the Roth Conference?

The announcement notes one-on-one investor meetings hosted by the CFO but does not mention a public presentation. According to electroCore, interested investors should request meetings via Roth or the company email for details.